BPG BIO
LIVE

Serial Number

97861879

Owner

BPGbio Inc.

Attorney

Lori J. Shyavitz, Esq.

Filing Date

Mar 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BPG BIO Trademark

Serial Number: 97861879

BPG BIO is a trademark filed by BPGbio Inc. on March 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

BPGbio Inc.

300 Third Avenue, 5th Floor
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

March 28, 2023

Registration Date

Not Registered

Published for Opposition

February 13, 2024

Goods & Services

Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprised of medical reagents for medical and clinical use in disease testing, bodily fluid testing, biometric testing, cardiovascular testing, heart rate testing, organ function testing, hydration testing, and nutrition testing

Pharmaceutical, scientific, medical, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical and scientific research information in the field of medicine and pharmaceuticals; Medical research services in the field of cancer; Medical testing for scientific research purposes in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Data mining; Research and development in the field of biomarkers; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Providing scientific information in the field of pharmaceuticals; Pharmaceutical and medical research in the field of outcomes research; Medical research featuring the identification and validation of disease related biomarkers for use in improved patient outcomes; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical data; Software as a service (SAAS) services featuring software for big data analytics, and for collecting and analyzing data in the field of healthcare; Providing on-line, non-downloadable computer software for use in accessing and importing scientific and medical data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Platform as a service (PAAS) featuring computer software platforms for data collection, data analytics, data storage and data mining, for use in the field of healthcare

Downloadable computer software for compiling and analyzing scientific and medical data; Recorded computer software for compiling and analyzing scientific and medical data; Downloadable computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Recorded computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Downloadable computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Recorded computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications

Providing medical information in the field of medicine and pharmaceuticals; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic, prognostic and theranostic screening and testing; Theranostic assessment of a disease or condition for medical purposes; Theranostic analysis services for medical purposes; Medical diagnostic and theranostic monitoring and reporting services; Health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; Predictive modeling of data in the fields of medicine and healthcare, for medical diagnostic, prognostic and treatment purposes; Providing health information; Medical information; Providing health information, medical information, disease management information, and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, said information provided to others

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2026 EXRA
SOU EXTENSION 4 GRANTED
Apr 7, 2026 EX4G
SOU EXTENSION 4 FILED
Apr 7, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 7, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 10, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 9, 2025 EX3G
SOU EXTENSION 3 FILED
Oct 9, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 10, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2024 EXRA
SOU EXTENSION 1 GRANTED
Nov 20, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 20, 2024 AITU
SOU EXTENSION 1 FILED
Oct 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 21, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2023 NWOS
NEW APPLICATION ENTERED
Mar 31, 2023 NWAP